ReviewMaterials (Basel, Switzerland)2023
Research Progress on Inactivation of Bacteriophages by Visible-Light Photocatalytic Composite Materials: A Mini Review.
Review in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging two-dimensional nanomaterial and its modifications for enhanced antiviral applications: a review.Royal Society open science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Infectious diseases caused by waterborne viruses have attracted researchers' great attention. To ensure a safe water environment, it is important to advance water treatment and disinfection technology. Photocatalytic technology offers an efficient and practical approach for achieving this goal. This paper reviews the latest studies on visible-light composite catalysts for bacteriophage inactivation, with a main focus on three distinct categories: modified UV materials, direct visible-light materials and carbon-based materials. This review gives an insight into the progress in photocatalytic material development and offers a promising solution for bacteriophage inactivation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.